Guillain-Barre syndrome in SARS CoV-2: Case series of uncommon neurological complication from tertiary care center, Bengaluru, South India

Authors

  • Mamatha Tittamegalapalya Ramalingaiah Associate Professor, Department of General Medicine, Employees State Insurance Post Graduate Institute of Medical Sciences and Research, Bengaluru, Karnataka, India https://orcid.org/0000-0003-2027-8141
  • Latha Venakataramanappa Assistant Professor, Department of General Medicine, Employees State Insurance Post Graduate Institute of Medical Sciences and Research, Bengaluru, Karnataka, India https://orcid.org/0000-0002-8064-744X
  • Sumedha Swamy Assistant Professor, Department of General Medicine, Employees State Insurance Post Graduate Institute of Medical Sciences and Research, Bengaluru, Karnataka, India
  • Virender Singh Resident, Department of General Medicine, Employees State Insurance Post Graduate Institute of Medical Sciences and Research, Bengaluru, Karnataka, India https://orcid.org/0000-0002-6362-9776
  • Vinutha Bagalur Srinivas Murthy Resident, Department of General Medicine, Employees State Insurance Post Graduate Institute of Medical Sciences and Research, Bengaluru, Karnataka, India https://orcid.org/0000-0003-1714-6578

DOI:

https://doi.org/10.3126/ajms.v14i2.48777

Keywords:

Guillian-barre syndrome, Coronavirus 2, Demyelination, Immunoglobulins

Abstract

Coronavirus disease is an infectious disease caused by severe acute respiratory syndrome-coronavirus 2 virus. It predominantly affects respiratory system causing fever, cough, and breathlessness. But it can also affect central nervous system and peripheral nervous system. It is important that physicians keep a high index of suspicion for patients with neurologic symptoms following a recent or during COVID-19 infection. The low rate of initial diagnosis is alarming, as few of the percentage of patients with Guillain-Barre syndrome will develop respiratory muscle weakness requiring invasive ventilation. The ability to recognize the disease process could lead to life saving management. Furthermore, the initiation of therapy such as plasma exchange or intravenous immunoglobulin leads to an accelerated recovery time.

Downloads

Download data is not yet available.
Abstract
127
PDF
115

Downloads

Published

2023-02-01

How to Cite

Mamatha Tittamegalapalya Ramalingaiah, Latha Venakataramanappa, Sumedha Swamy, Virender Singh, & Vinutha Bagalur Srinivas Murthy. (2023). Guillain-Barre syndrome in SARS CoV-2: Case series of uncommon neurological complication from tertiary care center, Bengaluru, South India. Asian Journal of Medical Sciences, 14(2), 234–240. https://doi.org/10.3126/ajms.v14i2.48777

Issue

Vol. 14 No. 2 (2023)

Section

Case Series

License

Copyright (c) 2022 Asian Journal of Medical Sciences

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. The journal holds copyright and publishes the work under a Creative Commons CC-BY-NC license that permits use, distribution and reprduction in any medium, provided the original work is properly cited and is not used for commercial purposes. The journal should be recognised as the original publisher of this work.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).